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Conclusions: Patients treated with an optimal treatment 
plan have 10% probability of experiencing treatment failure 
in terms of local recurrence or severe treatment related 
toxicity. In patients with suboptimal treatment plans the risk 
for treatment failure doubles. More, impact of dose volume 
constraints on the clinical results suggests that the highest 
priority in treatment planning should be given to reach the 
planning aims for the target dose coverage.  
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Purpose/Objective: Treatment of locally advanced cervical 
cancer involves multidisciplinary care using external beam 
radiotherapy, chemotherapy, brachytherapy, and surgery. We 
aimed to compare both tumor and treatment characteristics 
between with patients with complete pathologic response 
(CR) and patients with residual disease (RD). 
Materials and Methods: This monocentric restrospective 
study included 40 consecutive patients, treated with external 
beam radiotherapy, pulsed-dose-rate brachytherapy and 
completion surgery. Treatment planning was performed to 
obtain a cumulative D90 value for the intermediate-risk 
clinical target volume (IR-CTV) ≥ 60α/β=10. Different clinical 
and dosimetric parameters were analyzed and compared 
between patients with RD and those with CR. 
Results: We observed 18 (45%) patients with CR and 22 (55%) 
patients with RD. In univariate analysis, patients with RD had 
a significantly longer overall treatment time than those with 
CR (59.5 vs 53 days, p = 0.0321). The D90 value for the high-
risk CTV (HR-CTV) was higher in the group with CR than in the 
group with RD (65.9 vs 64.2Gyα/β=10, p = 0.0439). In 
multivariate analysis, overall treatment time remained the 
only predictive factor for CR (p = 0.033), even if the 
difference for D90 HR-CTV kept a trend toward significance (p 
= 0.057). 
Conclusions: This study showed that tumor sterilization is 
significantly correlated with overall treatment time and 
probably with cumulative dose delivered to the HR-CTV. 
These results emphasize the attention that must be given to 
treatment organization and dosimetry optimization.  
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Purpose/Objective: An ideal dosimeter for prostate 
brachytherapy should present high sensitivity, no 
dependencies on beam parameters, real-time and in-vivo 
dose measurement, independence of dose rate and 
temperature, dose linearity, tissue equivalence, be easy to 
use and calibrate, detectable in the anatomic volume to 
check its position, not expensive and with disposable use of 
its implantable part.  
Organic scintillating materials have been used for radiation 
detection for decades. Despite of the low density of these 
materials, their fast response and near water equivalence 
make them suitable for in-vivo and real-time dosimetry. We 
evaluated the performance of these materials under regimes 
such as the ones found in prostate Low Dose Rate (LDR) and 
High Dose Rate (HDR) brachytherapy. 
We developed a scintillator fiber optic dosimeter in two 
configurations suitable for both LDR and HDR prostate 
brachytherapy comprising two disposable probes adapted to 
both modalities. 
LDR typically uses low energy emitters (< 50 keV) and for that 
reason a high sensitivity device is required. Our detector uses 
a 5mm scintillating fiber optic optically coupled to a fiber 
optic waveguide with a silicon photomultiplier (SiPM) for light 
readout. SiPMs are solid-state devices, comprising multiple 
pixels that behave as Geiger-mode avalanche photodiode 
detectors individually. These devices allow the development 
of lower cost dosimetric devices but because they present a 
characteristic dark noise, we developed a patented solution 
to overcome this issue. 
On the other hand, HDR uses radiation with energies above 
the Cherenkov threshold for organic materials. This means 
that a blue light is present as a form of noise when a charged 
particle travels through the medium with a velocity higher 
than the velocity of light in that material.  
Materials and Methods: The scintillating fiber optic used is a 
BCF-12 (Saint-Gobain) optically coupled to a PMMA 1 mm core 
fiber optic (Avago Techonologies). The SiPM used is a 1mm2 
Multi-Pixel Photon Counter (MPPC) from Hamamatsu. 
Results: The dosimeter shows a linear response with dose and 
is capable of detecting mGy dose variations like an ionization 
chamber. Besides fulfilling all the requirements for a 
dosimeter in brachytherapy, the high sensitivity of this 
device makes it a suitable candidate for application in LDR-
brachytherapy. Energy linearity for energies below 50 keV 
using monochromatic x-ray photons will be presented.  
Conclusions: Clinical in-vitro tests were performed in 
collaboration with two Portuguese public hospitals and 
results from both LDR and HDR studies will be presented.  
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Purpose/Objective: We intend to show technical aspects of 
the treatment of facial and thoracic skin lesions with high 
dose rate (HDR) plesiotherapy. 
Materials and Methods: Eighteen treatments in sixteen 
patients with sarcoma, basal cell and squamous cell 
carcinoma in facial region (12) and cutaneous metastasis of 
breast cancer in thoracic region (6) were performed. Facial 
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areas included eyelid (1), nasal dorsum (7), pre auricular 
region (1), forehead (2) and cheek (1). The planning method 
was identical to all lesions, although two different 
immobilization techniques were applied, depending on the 
size and location of the lesion. The first technique was 
applied in facial lesions (11) and large lesions of the thorax 
(4): first the lesion was delineated with a radiopaque marker, 
followed by the immobilization of the patient with a 
thermoplastic mask, then one bolus plaque of 2 mm thickness 
was applied above the mask and the plastic catheters were 
placed and immobilized with two bolus plaques. The second 
technique was applied in small central lesions of the thorax 
(2) and in the eyelid: after the delineation of the lesion with 
a radiopaque marker, bolus plaques were placed directly 
above and the plastic catheters were placed and immobilized 
with two bolus plaques. In these cases, the limits of the mold 
were tattooed in the patient for reproducibility between 
fractions. The distance between catheters was always 10 
mm. A planning CT with 1,25 (facial) and 2,5 mm (thoracic) 
slice thickness was acquired. The treatment planning was 
developed by the treatment planning system (TPS) Oncentra 
MasterPlan v4.1 taking into account the prescription points, 
dose to the skin and doses to the organs at risk (OAR). The 
dose was prescribed to points at 0 (eyelid) and 3 mm depth. 
All patients were treated by a microSelectron v3 (Elekta) that 
used a 192Ir source. Eye protectors were used when necessary 
and the standard fractionation was 40 Gy in 10 fractions 
twice weekly. Dosimetric plans were analyzed for the 
following parameters: dose to the OAR, dose to the skin and 
dose to the prescribing points. The QA procedure was done 
using mosfets and gafchromic films.  
Results: The doses to the OAR were converted to Biologically 
Effective Dose (BED) and were always under their maximum 
tolerance dose. The dose verification results were accepted 
within a range of 10 % deviation of the planned dose to the 
prescribing points and to the skin. 
Conclusions: This technique showed to be a viable option to 
facial and thoracic skin lesions. Due to the steep dose 
gradient of the 192Ir sources used in brachytherapy, adjacent 
healthy tissue and deep structures are spared to irradiation. 
Furthermore, as masks and applicators are flexible, it is 
possible to treat lesions in irregular or curved surfaces 
assuring catheter fixation and treatment reproducibility 
between fractions. 
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Purpose/Objective: In the quality control program of the 
system used in prostate permanent implants (PPI) one of the 
tests should be the verification of mean value of seed 
strength of the whole lot of seeds to use in PPI. In this study 
we have compared the activity of two samples of seeds from 
the same cartridge. We measured mean value of air kerma 
strength (SK) of one sample with an ionization chamber, as 
the other sample was measured, in internal units, with the 
diode system integrated in the afterloader equipment. The 
lineal relationship found between both measures could be 
used to predict SK of the cartridge of seeds. 
Materials and Methods: Measured seeds, selectSeed I125, are 
contained in sterile cartridges. The cartridges included in the 
study were 19, used along 2013 and 2014. In all cases the 
cartridge calibration certificate determines a SK value of 
0.610 cGy/h cm2 with an uncertainty of ± 4%. Prostate seed 
implants were made more than seven days after the 
calibration certificate date. Nucletron application Software 
seedSelectron v1.26b controls the construction of each seed 
configuration. The source strength measured of each seed 
that is taken out of the cartridge by Nucletron afterloader, 
seedLoader, is registered in a log file.This measurement is 
made by diodes included in the afterloader. For each case in 
this study, the average value of all seeds used in the implant 
is calculated from the diode measurement (DL). Following the 
implant, SK of a seed sample from the cartridge is measured 
with well ionization chamber SourceCheck of PTW (whichever 
was smaller, 10% of the initial number of seeds in the 
cartridge or the seeds remaining therein). A decay factor is 
applied to this measure to obtain the corresponding value 
upon completion of the implant, i.e. when measured by the 
afterloader equipment. 
Results: Figure 1 shows the scatter plot with DL as an 
independent variable and the SK measurement of the 
chamber as a dependent variable (DV). The regression line 
(corrected R2 = 0.747) and the lines of CI 95% for individuals 
are included. Linear regression satisfies the assumptions of 
independence (Durbin-Watson = 2.063), homoscedasticity and 
normality of residuals (p=0.737 Shapiro-Wilk test). For 
residuals, standard deviation (SD) was 0.003 cGy/h cm2, i.e. 
0.5% of the mean value of the DV (0.552 cGy/h cm2). The 
mean value of coefficient of variation (CV) in measures with 
afterloader was 3.4% with SD 0.9% whereas with ionization 
chamber the mean value of CV was 1.9% with SD 0.7%. 
 
 
Conclusions: Measurements of diode array and use of the 
regression allow calculation of SK of the seed cartridge and 
the comparison with calibration certificate. Limit values of 
disagreement with manufacturer should be increased by 
±1.1%. Due to the higher value of CV, the afterloader has less 
accuracy than ionization chamber. Afterloader can not be 
used to compare source strength of individual seeds with the 
average value for cartridge. 
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